Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 201–300 of 999
Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction
Han, Y., Gong, Z., Sun, G., Xu, J., Qi, C., Sun, W., Jiang, H., Cao, P., & Ju, H. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680101 · Cited by 131
Emerging insights on intestinal dysbiosis during bacterial infections
Pham, T. A. N., & Lawley, T. D. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.12.002 · Cited by 114
Trubiano, J. A., Cheng, A. C., Korman, T. M., Röder, C., Campbell, A. J., May, M., Blyth, C. C., Ferguson, J., Blackmore, T., Riley, T. V., et al. (2016) · Internal Medicine Journal · doi:10.1111/imj.13027 · Cited by 129
Chemical Inhibitors of the Type Three Secretion System: Disarming Bacterial Pathogens
Duncan, M. C., Linington, R. G., & Auerbuch, V. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00975-12 · Cited by 116
Spore Formation and Toxin Production in Clostridium difficile Biofilms
Semenyuk, E. G., Laning, M. L., Foley, J., Johnston, P. F., Knight, K. L., Gerding, D. N., & Driks, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087757 · Cited by 151
“Colonization requires depletion or impairment of the host microbiota, usually due to administration of antimicrobials, as is common in hospitals [15,16].”
BackgroundMonteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0114 · Cited by 112
“A fiber-rich diet has been associated with increased microbial diversity (58), while a low gut microbial diversity has been correlated with recurrent Clostridium difficile infection, Crohn’s disease, and obesity (59, 60).”
Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients
Galloway-Peña, J. R., Smith, D. P., Sahasrabhojane, P., Wadsworth, W. D., Fellman, B. M., Ajami, N. J., Shpall, E. J., Daver, N., Guindani, M., Petrosino, J. F., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0409-1 · Cited by 112
“Moreover, despite many reports associating low microbial diversity with different illnesses, most studies associate only one-time microbiome measurements with subsequent clinical outcomes, which could be potentially problematic in settings of significant temporal variability [24, 26].”
BackgroundThe gut microbiota and graft-versus-host disease
Fredricks, D. N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125797 · Cited by 123
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea
Kim, J. W. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i28.3573 · Cited by 110
Zhang, W. Y., Ma, C., Xie, P., Zhu, Q., Wang, X., Yin, Y., & Kong, X. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14304 · Cited by 125
“2014) and contributes to a growing number of diseases, such as autoimmune diseases, obesity, inflammatory bowel disease and recurrent clostridium difficile-associated diarrhoea (Ott et al. 2004; Chang et al. 2008).”
BackgroundClostridium difficile infection: molecular pathogenesis and novel therapeutics
Rineh, A., Kelso, M. J., Vatansever, F., Tegos, G. P., & Hamblin, M. R. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.866515 · Cited by 137
Neemann, K., Eichele, D. D., Smith, P. W., Bociek, R., Akhtari, M., & Freifeld, A. (2012) · Transplant Infectious Disease · doi:10.1111/tid.12017 · Cited by 107
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine
Preidis, G. A., Saulnier, D. M., Blutt, S. E., Mistretta, T., Riehle, K. P., Major, A. M., Venable, S. F., Finegold, M. J., Petrosino, J. F., Conner, M. E., et al. (2012) · The FASEB Journal · doi:10.1096/fj.10-177980 · Cited by 107
“A highly diverse microbiome is considered optimal, given the strong correlations between decreased microbial diversity and recurrent diarrhea (42) or inflammatory bowel disease (43).”
BackgroundHoek, M. J. A. V., & Merks, R. M. H. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0430-4 · Cited by 107
“, because it facilitates colonization by pathogenic species including Clostridium difficile [58].”
BackgroundLapthorne, S., Pereira-Fantini, P. M., Fouhy, F., Wilson, G., Thomas, S. L., Dellios, N. L., Scurr, M., O’Sullivan, O., Ross, R. P., Stanton, C., et al. (2013) · Gut Microbes · doi:10.4161/gmic.24372 · Cited by 106
Staley, C., Kelly, C. R., Brandt, L. J., Khoruts, A., & Sadowsky, M. J. (2016) · mBio · doi:10.1128/mbio.01965-16 · Cited by 105
“Changes in the composition of the intestinal microbial community as a result of antibiotic exposure in patients with rCDI have been well characterized by using several molecular approaches, including next-generation sequencing (13, 16, 21–23).”
Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth
Engevik, M. A., Aihara, E., Montrose, M. H., Shull, G. E., Hassett, D. J., & Worrell, R. T. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00184.2013 · Cited by 105
“3 Introduction: 48 The alteration of normal gut microbiota is known to play a role in a variety of complex diseases such as 49 obesity (85), (51), (52), (86), (2), (84), (3), diabetes (9), (47), Inflammatory Bowel Disease (28), (30), (68), 50 (56), (70), Antibiotic-associated diarrhea (92) and Clostridium difficile-as…”
BackgroundHorrocks, V., King, O. G., Yip, A. Y. G., Marques, I. M., & McDonald, J. A. K. (2023) · Microbiology · doi:10.1099/mic.0.001377 · Cited by 104
Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile
Engevik, M. A., Engevik, K. A., Yacyshyn, M. B., Wang, J., Hassett, D. J., Darien, B., Yacyshyn, B. R., & Worrell, R. T. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00090.2014 · Cited by 104
“3B), consistent with other 331 reports (13).”
Gootenberg, D. B., Paer, J. M., Luévano, J. M., & Kwon, D. S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000341 · Cited by 110
“individuals often have reduced diversity of their enteric microbiome, which is also observed in a number of pathologies such as IBD [87–89], type 1 diabetes mellitus [90], obesity [91], and Clostridium difficile infection [92,93].”
BackgroundTuddenham, S., Koay, W. L. A., Zhao, N., White, J. R., Ghanem, K. G., Sears, C. L., Dillon, S. M., Wilson, C. C., Lozupone, C., Ward, H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz258 · Cited by 117
Kulecka, M., Frączek, B., Mikuła, M., Żeber‐Lubecka, N., Karczmarski, J., Paziewska, A., Ambrożkiewicz, F., Jagusztyn-Krynicka, E. K., Cięszczyk, P., & Ostrowski, J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1758009 · Cited by 125
Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms
Thomas, A. M., Gleber‐Netto, F. O., Fernandes, G. R., de Amorim, M. G., Barbosa, L., Francisco, A. L. N., de Andrade, A. G., Setúbal, J. C., Kowalski, L. P., Nunes, D. N., et al. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0250-2 · Cited by 120
“A reduction in microbial diversity has been associated with other diseases such as irritable bowel syndrome [46], eczema [47], Crohn’s disease [48], obesity [49] and recurrent Clostridium difficileassociated diarrhea [50], evidencing the crucial role that commensal bacteria play on keeping pathogenic microbes at bay a…”
BackgroundBaktash, A., Terveer, E. M., Zwittink, R. D., Hornung, B. V. H., Corver, J., Kuijper, E. J., & Smits, W. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01242 · Cited by 102
“Furthermore, patients with recurrent CDI showed lower species richness compared with patients with an initial episode of CDI patients and control subjects (Chang et al., 2008; Seekatz et al., 2016).”
BackgroundHourigan, S. K., Chen, L. A., Grigoryan, Z., Laroche, G., Weidner, M., Sears, C. L., & Oliva‐Hemker, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13326 · Cited by 101
“Decreased diversity of the microbiome is reported as associated with recurrent CDI.(50) Hence, we speculate that the loss of”
BackgroundInfluentialBrown, J. R.-M., Flemer, B., Joyce, S. A., Zulquernain, A., Sheehan, D., Shanahan, F., & O’Toole, P. W. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0860-5 · Cited by 99
Vrieze, A., de Groot, P. F., Kootte, R. S., Knaapen, M., van Nood, E., & Nieuwdorp, M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.003 · Cited by 120
“000 cases are seen annually (45) and this infection is also associated with decreased microbial diversity and altered composition (46).”
BackgroundFecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Brandt, L. J., & Reddy, S. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318222e603 · Cited by 98
Microbial Ecology of the Bivalvia, with an Emphasis on the Family Ostreidae
Pierce, M. L., & Ward, J. E. (2018) · Journal of Shellfish Research · doi:10.2983/035.037.0410 · Cited by 108
Frenemies: Signaling and Nutritional Integration in Pathogen-Microbiota-Host Interactions
Cameron, E. A., & Sperandio, V. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.007 · Cited by 97
“CDI is often preceded by antibiotic use or another disturbance in the normal composition of the patient’s microbiota that decreases the diversity of the population (Chang et al., 2008).”
BackgroundHuman Pharyngeal Microbiome May Play A Protective Role in Respiratory Tract Infections
Gao, Z., Kang, Y., Yu, J. M., & Ren, L. (2014) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2014.06.001 · Cited by 107
“Diversity is a major factor that promotes system stability [33], loss of diversity thus lessens the protective effects of the microbiome and renders patients vulnerable to infection.”
BackgroundNavaneethan, U. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i39.4892 · Cited by 97
Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile
Hunt, J. J., & Ballard, J. D. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-13 · Cited by 112
Dubourg, G., Lagier, J., Hüe, S., Surénaud, M., Bachar, D., Robert, C., Michelle, C., Ravaux, I., Mokhtari, S., Million, M., et al. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000080 · Cited by 106
Minkoff, N. Z., Aslam, S., Medina, M., Tanner‐Smith, E. E., Zackular, J. P., Acra, S. A., Nicholson, M. R., & Imdad, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013871.pub2 · Cited by 207
Recurrent Clostridium difficile infection: From colonization to cure
Shields, K., Araujo-Castillo, R. V., Theethira, T. G., Alonso, C. D., & Kelly, C. P. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.04.012 · Cited by 93
Frost, F., Weiß, F. U., Sendler, M., Kacprowski, T., Rühlemann, M. C., Bang, C., Franke, A., Völker, U., Völzke, H., Lamprecht, G., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000232 · Cited by 106
Fecal microbiota transplantation: facts and controversies
van Nood, E., Speelman, P., Nieuwdorp, M., & Keller, J. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000024 · Cited by 92
Impacts of florfenicol on the microbiota landscape and resistome as revealed by metagenomic analysis
Zeng, Q., Liao, C., Terhune, J. S., & Wang, L. (2019) · Microbiome · doi:10.1186/s40168-019-0773-8 · Cited by 96
The Human Microbiome and the Missing Heritability Problem
Sandoval-Motta, S., Aldana, M., Martínez-Romero, E., & Frank, A. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00080 · Cited by 90
“In fact, infections by this pathogen are known to persist in human hosts even after the removal of the drug (Chang et al., 2008; Manges et al., 2010).”
BackgroundWick, E. C., & Sears, C. L. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833da1eb · Cited by 96
Zhao, T.-S., Xie, L., Cai, S., Xu, J., Zhou, H., Tang, L., Yang, C., Fang, S., Li, M., & Tian, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.717636 · Cited by 96
“On contrary, a decrease in the diversity of gut microbiota (dysbiosis) might cause many intestinal diseases (Ott et al., 2004; Manichanh et al., 2006; Chang et al., 2008; Willing et al., 2010; Lepage et al., 2011; Sokol et al., 2017; Mentella et al., 2020).”
BackgroundBailey, M. T. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_12 · Cited by 96
Probiotics in Clostridium difficile Infection
Na, X., & Kelly, C. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822ec787 · Cited by 88
“A disturbed colonic microflora leads to a loss of colonization resistance and hence becomes vulnerable to CDI and CDI recurrences.(15,16) The classic example of the importance of colonization resistance to C.”
Bonsaglia, É. C. R., Gomes, M. S., Canisso, I. F., Zhou, Z., Lima, S. F., Rall, V. L. M., Oikonomou, G., Bicalho, R. C., & de Lima, F. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08790-5 · Cited by 105
Mefferd, C. C., Bhute, S. S., Phan, J. R., Villarama, J. V., Do, D. M., Alarcia, S., Abel‐Santos, E., & Hedlund, B. P. (2020) · mSystems · doi:10.1128/msystems.00765-19 · Cited by 95
van Eijk, E., Wittekoek, B., Kuijper, E. J., & Smits, W. K. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw548 · Cited by 114
Patient Perceptions of Fecal Microbiota Transplantation for Ulcerative Colitis
Kahn, S. A., Vachon, A., Rodriquez, D., Goeppinger, S. R., Surma, B., Marks, J., & Rubin, D. T. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f520 · Cited by 85
Probiotics and irritable bowel syndrome
Dai, C. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i36.5973 · Cited by 85
Lee, Y. J., Arguello, E. S., Jenq, R. R., Littmann, E., Kim, G. J., Miller, L. C., Ling, L., Figueroa, C., Robilotti, E., Perales, M.-A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix011 · Cited by 84
“In contrast to this finding, prior microbiome studies have observed decreased diversity in association with CDI [16, 17, 20, 22]; however, in those studies, fecal samples were collected and examined at or after CDI diagnosis, making it difficult to separate the effects of the disease process and antibiotic treatment f…”
ResultEngevik, M. A., Engevik, A. C., Engevik, K. A., Auchtung, J. M., Chang‐Graham, A. L., Ruan, W. H., Luna, R. A., Hyser, J. M., Spinler, J. K., & Versalovic, J. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00634 · Cited by 99
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Hou, S., Yu, J., Li, Y., Zhao, D., & Zhang, Z. (2025) · Advanced Science · doi:10.1002/advs.202413197 · Cited by 117
Exploring the salivary microbiome of children stratified by the oral hygiene index
Mashima, I., Theodorea, C. F., Thaweboon, B., Thaweboon, S., Scannapieco, F. A., & Nakazawa, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185274 · Cited by 94
Helicobacter pylori infection associates with fecal microbiota composition and diversity
Frost, F., Kacprowski, T., Rühlemann, M. C., Bang, C., Franke, A., Zimmermann, K., Nauck, M. A., Völker, U., Völzke, H., Biffar, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56631-4 · Cited by 94
From Animalcules to an Ecosystem: Application of Ecological Concepts to the Human Microbiome
Fierer, N., Ferrenberg, S., Flores, G. E., González, A., Kueneman, J., Legg, T., Lynch, R. C., McDonald, D., Mihaljevic, J. R., O'Neill, S. P., et al. (2012) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev-ecolsys-110411-160307 · Cited by 84
“Similarly, there is a dearth of empirical data indicating whether people with high or low diversity microbiomes are more prone or resistant to disease, although there is some evidence suggesting that such relationships may exist (Chang et al. 2008, Mazmanian et al. 2008, Packey & Sartor 2009).”
BackgroundAnalysis of Bacterial Communities during Clostridium difficile Infection in the Mouse
Semenyuk, E. G., Poroyko, V. A., Johnston, P. F., Jones-Burrage, S. E., Knight, K. L., Gerding, D. N., & Driks, A. (2015) · Infection and Immunity · doi:10.1128/iai.00145-15 · Cited by 92
“Several studies found overall changes in the composition of the microbiota during CDI that resembled those found here, although the specific bacteria were not always identified (4, 15, 38, 39).”
BackgroundInstability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome
Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83
“…is typical of re-establishing communities after disturbance, as seen in the faecal microbiota of subjects treated with antibiotics or dietary interventions or in patients with recurrent Clostridium difficile–associated diarrhoea (Chang et al., 2008; Dethlefsen & Relman, 2011; Wu et al., 2011).”
BackgroundAcute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters
Partrick, K. A., Chassaing, B., Beach, L. Q., McCann, K. E., Gewirtz, A. T., & Huhman, K. L. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.005 · Cited by 83
The Appendix May Protect Against Clostridium difficile Recurrence
Im, G. Y., Modayil, R. J., Lin, C. T., Geier, S. J., Katz, D. S., Feuerman, M., & Grendell, J. H. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.06.006 · Cited by 94
Knecht, H., Neulinger, S. C., Heinsen, F., Knecht, C., Schilhabel, A., Schmitz, R. A., Zimmermann, A., dos Santos, V. A. P. M., Ferrer, M., Rosenstiel, P. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089417 · Cited by 106
Colonization Resistance of the Gut Microbiota against Clostridium difficile
Pérez-Cobas, A., Moya, A., Gosalbes, M., & Latorre, A. (2015) · Antibiotics · doi:10.3390/antibiotics4030337 · Cited by 83
“intermediate diversity pattern between recurrent CDI patients and controls [98].”
BackgroundNovel Risk Factors for Recurrent Clostridium difficile Infection in Children
Nicholson, M. R., Thomsen, I. P., Slaughter, J. C., Creech, C. B., & Edwards, K. M. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000553 · Cited by 87
“A 2008 study demonstrated that in adults with rCDI, the fecal microbiome was significantly decreased in phylotype richness compared with patients who experienced a single episode of CDI (30).”
BackgroundEnteric pathogens through life stages
Kolling, G. L., Wu, M., & Guerrant, R. L. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00114 · Cited by 98
“As already mentioned, a loss of species diversity and richness within the microbiota has been observed in IBD and CDI; in addition, based on their relative abundance, facultative anaerobes including members of Proteobacteria appear to thrive.”
ResultInfluentialA Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics
Allen-Vercoe, E., Reid, G., Viner, N., Gloor, G. B., Hota, S., Kim, P., Lee, C., O’Doherty, K. C., Vanner, S. J., Weese, J. S., et al. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/213828 · Cited by 81
“Recurrent CDI is believed to result from the inability of the intestinal microbiota to recover and re-establish itself to homeostasis with the host (we henceforth use the term ‘normal’ to mean one that does not cause symptoms and signs of infection), after an initial insult, such as antimicrobial exposure (7-10).”
BackgroundTheriot, C. M., & Young, V. B. (2014) · Gut Microbes · doi:10.4161/gmic.27131 · Cited by 80
“found that patients with recurrent CDAD had decreased diversity of the fecal microbiota with highly variable bacterial composition.(93) A more recent study following successful fecal bacterial transplantation of three subjects observed an increase in Firmicutes and Bacteroidetes (Bacteroidaceae, Rikenellaceae and Porp…”
BackgroundSelf-citationThe role of Clostridium difficile in the paediatric and neonatal gut — a narrative review
Lees, E. A., Miyajima, F., Pirmohamed, M., & Carrol, E. D. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2639-3 · Cited by 91
“difficile disease/recurrence in adults [23].”
Microbiologic factors affecting Clostridium difficile recurrence
Chilton, C. H., Pickering, D. S., & Freeman, J. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.017 · Cited by 85
“demonstrated SWIヴW;ゲWS ゲヮWIキWゲ けヴキIエミWゲゲ in faecal microbiomes of rCDI 95 patients versus healthy controls and patients with a single CDI episode.(28) 96”
Clostridium difficile Infection: An Epidemiology Update
Roo, A. C. D., & Regenbogen, S. E. (2020) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0040-1701229 · Cited by 95
Hullar, M. A. J., Lancaster, S. M., Li, F., Tseng, E., Beer, K. D., Atkinson, C., Wähälä, K., Copeland, W. K., Randolph, T. W., Newton, K. M., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0262 · Cited by 87
“For example, dietary patterns that were associated with decreased microbiome structural and functional diversity have been associated with obesity (69), reduced cognitive function in the elderly (41), Clostridium difficile–associated disease (70), and irritable bowel disease (26).”
BackgroundMicrobiome alterations in HIV infection a review
Williams, B., LANDAY, A. L., & Presti, R. M. (2016) · Cellular Microbiology · doi:10.1111/cmi.12588 · Cited by 85
“Based on studies of intestinal inflammatory states it was suspected that those with HIV would have lower alpha diversity (Chang et al., 2008; Willing et al., 2010).”
BackgroundFecal Microbiota Transplantation for the Management of Clostridium difficile Infection
Rao, K. K., & Young, V. B. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.009 · Cited by 88
Self-citationZainah, H., Hassan, M. M., Sroujieh, L., Hassan, S., Alangaden, G. J., & Ramesh, M. S. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3296-y · Cited by 87
“Recurrent CDI is believed to be in part due to the persistent loss of diversity of this fecal microbiota even after discontinuation of antibiotics [13].”
Engevik, M. A., Banks, L. D., Engevik, K. A., Chang‐Graham, A. L., Perry, J. L., Hutchinson, D. S., Ajami, N. J., Petrosino, J. F., & Hyser, J. M. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1754714 · Cited by 87
Seasonal Allergic Rhinitis Affects Sinonasal Microbiota
Choi, C. H., Poroyko, V. A., Watanabe, S., Jiang, D., Lane, J. D., deTineo, M., Baroody, F. M., Naclerio, R. M., & Pinto, J. M. (2014) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2014.28.4050 · Cited by 85
Age-Related Variations in Intestinal Microflora of Free-Range and Caged Hens
Cui, Y., Wang, Q., Liu, S., Sun, R. Q., YaQiang, Z., & Li, Y. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01310 · Cited by 90
“Also some research investigated that intestinal microflora disorders or imbalance might be relevant to some intestinal diseases like inflammatory bowel disease or obesity-associated diabetes (Chang et al., 2008; Michail et al., 2012; Murri et al., 2013; Huang et al., 2017).”
BackgroundCarlucci, C., Petrof, E. O., & Allen-Vercoe, E. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.029 · Cited by 77
“…reduced overall bacterial diversity, characterized by increases in Proteobacteria with decreases in Firmicutes and Bacteroidetes phyla in comparison to healthy subjects (Antharam et al., 2013; Chang et al., 2008; Fuentes et al., 2014; Rea et al., 2012; Schubert et al., 2014; Shahinas et al., 2012).”
BackgroundSeekatz, A. M., Safdar, N., & Khanna, S. (2022) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221134396 · Cited by 101
Inside Out: HIV, the Gut Microbiome, and the Mucosal Immune System
Liu, J., Williams, B., Frank, D. N., Dillon, S. M., Wilson, C. C., & LANDAY, A. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601355 · Cited by 85
“Loss of fecal microbial diversity has been noted in the settings of Clostridium difficile colitis and inflammatory bowel disease (51, 52).”
BackgroundYao, Z., Yang, K., Huang, L., Huang, X., Qiuqian, L., Wang, K., & Zhang, D. (2018) · AMB Express · doi:10.1186/s13568-018-0644-x · Cited by 81
Ross, C. L., Spinler, J. K., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.006 · Cited by 87
van Beurden, Y. H., de Groot, P. F., van Nood, E., Nieuwdorp, M., Keller, J. J., & Goorhuis, A. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640616678099 · Cited by 76
“Between July 2010 and January 2016, 43 patients were treated with FMT for recurrent CDI.”
BackgroundInfluentialThe role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
“Disruption in microbiota composition is profound in patients with recurrent CDI, who have received multiple antibiotic courses [45].”
BackgroundHost Response to Probiotics Determined by Nutritional Status of Rotavirus‐infected Neonatal Mice
Preidis, G. A., Saulnier, D. M., Blutt, S. E., Mistretta, T., Riehle, K. P., Major, A. M., Venable, S. F., Barrish, J. P., Finegold, M. J., Petrosino, J. F., et al. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31824d2548 · Cited by 75
“Perturbations of the human intestinal microbiome are speculated to play a role in rotavirus pathogenesis (47), although it is not known whether microbial population changes contribute to or result from the disease process; however, increased intestinal microbiome diversity appears to be protective against other gastro…”
Ericsson, A. C., Personett, A. R., Turner, G., Dorfmeyer, R. A., & Franklin, C. L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00196 · Cited by 86
“In this context, FMT recipients are already subject to significantly decreased microbial diversity (Chang et al., 2008), typically owing to antibiotic administration prior to the proliferation of C.”
BackgroundClostridium Difficile Infection
Luciano, J. A., & Zuckerbraun, B. S. (2014) · Surgical Clinics of North America · doi:10.1016/j.suc.2014.08.006 · Cited by 80
Castro‐Nallar, E., Shen, Y., Freishtat, R. J., Pérez‐Losada, M., Manimaran, S., Liu, G., Johnson, W. E., & Crandall, K. A. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0121-1 · Cited by 77
“Decreased microbial diversity have also been observed in other human diseases [39–41], although increased diversity in diseased patients has also been noted [42].”
BackgroundThe sinonasal bacterial microbiome in health and disease
Ramakrishnan, V. R., Hauser, L. J., & Frank, D. N. (2015) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000221 · Cited by 81
Bella, S. D., Gouliouris, T., & Petrosillo, N. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.01.011 · Cited by 77
New concepts in diagnostics for infectious diarrhea
Platts-Mills, J., Liu, J., & Houpt, E. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.50 · Cited by 70
Management of inflammatory bowel disease withClostridium difficileinfection
D’Aoust, J., Battat, R. J., & Bessissow, T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i27.4986 · Cited by 84
Inhibition of Fungal Pathogens across Genotypes and Temperatures by Amphibian Skin Bacteria
Muletz‐Wolz, C. R., Almario, J. G., Barnett, S. E., DiRenzo, G. V., Martel, A., Pasmans, F., Zamudio, K. R., Toledo, L. F., & Lips, K. R. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01551 · Cited by 75
“Amphibians and their microbiomes will continue to be exposed to rapidly evolving Batrachochytrium genotypes, and hosts harboring higher numbers of microbial taxa and hence more potentially inhibitory species may provide greater resistance to pathogen invasion than microbiome communities with fewer taxa (Chang et al.,…”
BackgroundInfluentialGut microbiome and Clostridioides difficile infection: a closer look at the microscopic interface
Sehgal, K., & Khanna, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284821994736 · Cited by 80
Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy
Shirley, D.-A. T., Tornel, W., Warren, C. A., & Moonah, S. N. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062307 · Cited by 93
“48 Risk factors for recurrence include the presence of co-morbidities such as cancer, IBD, medical technology dependence, recent surgery, and antibiotic exposure.”
BackgroundAntimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
Vincent, C., & Manges, A. R. (2015) · Antibiotics · doi:10.3390/antibiotics4030230 · Cited by 82
“used 16S rRNA gene clone libraries to compare the fecal communities of four patients with an initial episode of CDI, three patients with recurrent CDI and three healthy control subjects [51].”
MethodFecal Microbiota Transplantation in the Treatment of Clostridium difficile Infections
Austin, M., Mellow, M., & Tierney, W. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.02.017 · Cited by 78
Recurrent Clostridium difficile infection: causality and therapeutic approaches
Johnson, S. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70014-7 · Cited by 76
Clinical translation of microbe‐based therapies: Current clinical landscape and preclinical outlook
Vargason, A. M., & Anselmo, A. C. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10093 · Cited by 71
“diff infections (RCDI).(17,18) These risks, particularly with RCDI, have generated significant interest in developing alternative therapies that mitigate the killing of commensal bacteria and the evolution of antibiotic-resistant pathogens.”
BackgroundFecal microbiota transplantation for the treatment of Clostridium difficile infection
Rao, K., & Safdar, N. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2449 · Cited by 70
“Conventional treatments (Table 1) utilize antibiotics with activity against C difficile,(20,21) but these antibiotics have activity against other gut bacteria, limiting the ability of the microbiota to fully recover following CDI and predisposing patients to recurrence.(22) Traditional treatments for CDI result in a h…”
MethodGut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes
Skraban, J., Dzeroski, S., Zenko, B., Mongus, D., Gangl, S., & Rupnik, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058005 · Cited by 70
Bassis, C. M., Theriot, C. M., & Young, V. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02262-13 · Cited by 67
Self-citation
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.